Executive Director, US Portfolio Analytics
US$265,000 – US$331,000 / yr base salary
Posted 24 Sep 2026
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 12+ yrs
- Management level
- People management
- Employment
- On-Site
| Base salary | US$265,000 – US$331,000 / yr |
|---|
Field of studyBusiness, Engineering, Quantitative Studies, Science
Study levelBachelor's
CertificationsMaster of Business Administration
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting directly to the Vice President, US Analytics & Insights, the Executive Director, US Portfolio Analytics will lead the portfolio-wide analytics capabilities that enable data-driven commercial decision-making across Revolution Medicines’ US business. This leader will be accountable for Field Analytics, Market Access Analytics, Data Strategy & Governance, Omnichannel Analytics, and Dashboards, ensuring scalable, integrated capabilities that support launch readiness, commercialization, and performance management across the portfolio.
This role will serve as a strategic thought partner to US Commercial leadership and franchise Analytics & Insights leaders, translating business priorities into an integrated analytics roadmap and establishing consistent standards, methodologies, data definitions, and decision support across brands and functions. The Executive Director will operate as a player/coach—personally engaging in high-priority analyses and capability design while building, leading, and developing a high-performing team.
Candidates should bring deep biopharma commercial analytics expertise, strong business and technical acumen, and a track record of building scalable analytics capabilities in an agile, fast-growing organization. This position is based out of our headquarters in Redwood City, CA.
Specifically, you will be responsible for:
-
Portfolio analytics leadership. Serve as the senior leader for US Portfolio Analytics, defining the vision, operating model, capability roadmap, resourcing requirements, and prioritization approach for analytics across the US portfolio.
-
Field Analytics. Lead the Field Analytics team and oversee field analytics strategy and execution, including healthcare professional (HCP) and account segmentation and targeting, field-force sizing and alignment and analytics, and field performance measurement. In collaboration with Field leadership and Field Operations, establish national, regional, territory, and account-level performance frameworks, KPIs, dashboards, and analytics that identify leading indicators, execution gaps, growth opportunities, and actions for field leadership. Partner closely with Field Operations to provide analytics supporting field-force design and optimization, productivity, resource allocation, and incentive compensation.